Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
Rotavirus infection is a common cause of severe diarrheal disease and a major cause of deaths and hospitalizations among young children. Incidence of rotavirus has declined globally with increasing vaccine coverage. However, it remains a significant cause of morbidity and mortality in low-income cou...
Main Authors: | Nicholas Geard, Richard Bradhurst, Nefel Tellioglu, Vicka Oktaria, Jodie McVernon, Amanda Handley, Julie E. Bines |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2139097 |
Similar Items
-
Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
by: Geard, Nicholas, et al.
Published: (2022) -
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi
by: Benjamin Morgan, et al.
Published: (2024-09-01) -
Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine
by: Daniel Cowley, et al.
Published: (2018-08-01) -
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
by: Prashant Kumar, et al.
Published: (2021-07-01) -
Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants
by: Mercedes Macías-Parra, et al.
Published: (2024-02-01)